Potassium bicarbonate/potassium citrate - Advicenne

Drug Profile

Potassium bicarbonate/potassium citrate - Advicenne

Alternative Names: ADV 7103; Potassium citrate monohydrated/potassium hydrogen carbonate - Advicenne; Potassium citrate/potassium bicarbonate - Advicenne; Potassium hydrogen carbonate/potassium citrate monohydrated - Advicenne

Latest Information Update: 11 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Advicenne
  • Class Alkalinising agents; Citrates; Electrolytes; Potassium compounds; Small molecules; Urologics
  • Mechanism of Action Electrolyte replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Kidney disorders
  • New Molecular Entity No

Highest Development Phases

  • Phase III Kidney disorders

Most Recent Events

  • 04 Jul 2018 Efficacy and safety data from a phase III trial in Distal renal tubular acidosis released by Advicenne
  • 15 May 2018 Advicenne announces intention to launch potassium bicarbonate/potassium citrate for Kidney disorders (distal renal tubular acidosis) in Europe in 2020
  • 15 May 2018 Advicenne announces intention to launch potassium bicarbonate/potassium citrate for Kidney disorders (distal renal tubular acidosis) in USA in 2021
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top